Adjuvant Pembrolizumab in Resected Stage III Melanoma

Alexander M M Eggermont^{1

2}, Caroline Robert¹, Stefan Suciu³

Affiliations

¹ Gustave Roussy Cancer Campus Grand Paris, Villejuif, France
² alexander.eggermont@gustaveroussy.fr
³ European Organization for the Research and Treatment of Cancer Headquarters, Brussels, Belgium

Comment

Alexander M M Eggermont et al. N Engl J Med. 2018.

. 2018 Aug 9;379(6):593-595.

doi: 10.1056/NEJMc1807505.

Alexander M M Eggermont^{1

2}, Caroline Robert¹, Stefan Suciu³

¹ Gustave Roussy Cancer Campus Grand Paris, Villejuif, France
² alexander.eggermont@gustaveroussy.fr
³ European Organization for the Research and Treatment of Cancer Headquarters, Brussels, Belgium

No abstract available

Comment on

Adjuvant Pembrolizumab in Resected Stage III Melanoma.
Barker CA. Barker CA. N Engl J Med. 2018 Aug 9;379(6):593. doi: 10.1056/NEJMc1807505. N Engl J Med. 2018. PMID: 30091350 No abstract available.